Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial.
By R. F. Riemersma-Van der Lek, Dick F. Swaab, J. Twisk, E. Hol, W. Hoogendijk, E. V. Van Someren. Journal of the American Medical Association (JAMA), 2008
807 citations recorded by the source corpus.
Subfields: Anthropology, Political Science and International Relations, Sociology and Political Science
View Paper: https://www.semanticscholar.org/paper/912ea81101e1b8c61fea35a8c471c7a97fd6219f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Till Roenneberg
- M. Merrow
- D. Cardinali
- R. Hardeland
- S. Pandi‑Perumal
- Jun-Ping Liu
- D. Spence
- V. Srinivasan
Citations in the corpus
- Polymorphism of human cytochrome P450 enzymes and its clinical impact (2009, background): “…as a therapeutic agent in a number of conditions, including sleep disturbance, jet lag, Parkinson’s disease, depression, epilepsy, dementia, and metastatic cancer (Dowling et al., 2005; Lemoine et al., 2007; Riemersma-van der Lek et al., 2008; Singer et al., 2003; Van der Heijden et al., 2007).”
- The Circadian Clock and Human Health. (2016, background): “Some of this may be due to disease-associated pathology [46,47], but there are also indications that low amplitude light– dark cycles contribute to this condition [48].”
- Melatonin--a pleiotropic, orchestrating regulator molecule. (2011, background): “…of melatonergic receptors, the chances of alleviating symptoms such as sundowning and disturbed sleep by melatonin treatment, which is moderately possible in earlier stages (Furio et al., 2007; Riemersma-van der Lek et al., 2008; Cardinali et al., 2010) seem to vanish in late Alzheimer patients.”